Short answer · Medically reviewed summary · Last updated: 2026-05-08
CLOVES syndrome is a rare overgrowth disorder caused by somatic activating mutations in the PIK3CA gene, requiring a multidisciplinary approach to manage complex vascular malformations and tissue overgrowth. While an initial diagnosis of CLOVES syndrome is overwhelming, specialized care and connection with community support can significantly improve long-term outcomes and quality of life. How do I build the right care team for CLOVES syndrome? Because CLOVES syndrome affects multiple systems—including the skin, skeletal, and vascular structures—you need a "medical home." Start by seeking a center of excellence that specializes in PIK3CA-related overgrowth spectrum (PROS).
CLOVES syndrome is a rare overgrowth disorder caused by somatic activating mutations in the PIK3CA gene, requiring a multidisciplinary approach to manage complex vascular malformations and tissue overgrowth. While an initial diagnosis of CLOVES syndrome is overwhelming, specialized care and connection with community support can significantly improve long-term outcomes and quality of life.
Because CLOVES syndrome affects multiple systems—including the skin, skeletal, and vascular structures—you need a "medical home." Start by seeking a center of excellence that specializes in PIK3CA-related overgrowth spectrum (PROS). Your team should ideally include a pediatric or adult geneticist, a vascular interventional radiologist, an orthopedic surgeon, and a dermatologist. Coordinating care through a single lead specialist helps prevent fragmented treatment.
Managing the daily impact of CLOVES syndrome involves proactive symptom monitoring and energy conservation. Focus on these practical steps:
Connecting with others who have CLOVES syndrome reduces isolation and provides practical, "lived-experience" knowledge. Currently, 7 members within the DiseaseMaps.org community are navigating life with CLOVES syndrome, offering a unique space to share experiences with treatments and daily management tips that you won't find in textbooks.
Research into targeted therapies, such as PI3K inhibitors, is rapidly evolving. Stay informed by monitoring clinical trial registries and patient-led foundations. Being an active participant in your care—and potentially in research—empowers you to make informed decisions about emerging treatment options for CLOVES syndrome.
Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; please consult your primary care physician or a specialist for personalized clinical guidance.